2025-04-012025-12-312025-12-31false14728067GENETIX LIMITED2026-09-0986900falseiso4217:GBPxbrli:pure147280672025-03-31147280672025-12-31147280672025-04-012025-12-31147280672024-03-31147280672025-03-31147280672024-04-012025-03-3114728067bus:SmallEntities2025-04-012025-12-3114728067bus:AuditExempt-NoAccountantsReport2025-04-012025-12-3114728067bus:AbridgedAccounts2025-04-012025-12-3114728067bus:PrivateLimitedCompanyLtd2025-04-012025-12-3114728067core:WithinOneYear2025-12-3114728067core:AfterOneYear2025-12-3114728067core:WithinOneYear2025-03-3114728067core:AfterOneYear2025-03-311472806712025-04-012025-12-3114728067core:ShareCapital2025-12-3114728067core:SharePremium2025-12-3114728067core:RevaluationReserve2025-12-3114728067core:OtherReservesSubtotal2025-12-3114728067core:RetainedEarningsAccumulatedLosses2025-12-3114728067core:ShareCapital2025-03-3114728067core:SharePremium2025-03-3114728067core:RevaluationReserve2025-03-3114728067core:OtherReservesSubtotal2025-03-3114728067core:RetainedEarningsAccumulatedLosses2025-03-3114728067core:LandBuildings2025-12-3114728067core:PlantMachinery2025-12-3114728067core:Vehicles2025-12-3114728067core:FurnitureFittings2025-12-3114728067core:OfficeEquipment2025-12-3114728067core:NetGoodwill2025-12-3114728067core:IntangibleAssetsOtherThanGoodwill2025-12-3114728067core:ListedExchangeTraded2025-12-3114728067core:UnlistedNon-exchangeTraded2025-12-3114728067core:LandBuildings2025-03-3114728067core:PlantMachinery2025-03-3114728067core:Vehicles2025-03-3114728067core:FurnitureFittings2025-03-3114728067core:OfficeEquipment2025-03-3114728067core:NetGoodwill2025-03-3114728067core:IntangibleAssetsOtherThanGoodwill2025-03-3114728067core:ListedExchangeTraded2025-03-3114728067core:UnlistedNon-exchangeTraded2025-03-3114728067core:LandBuildings2025-04-012025-12-3114728067core:PlantMachinery2025-04-012025-12-3114728067core:Vehicles2025-04-012025-12-3114728067core:FurnitureFittings2025-04-012025-12-3114728067core:OfficeEquipment2025-04-012025-12-3114728067core:NetGoodwill2025-04-012025-12-3114728067core:IntangibleAssetsOtherThanGoodwill2025-04-012025-12-3114728067core:ListedExchangeTraded2025-04-012025-12-3114728067core:UnlistedNon-exchangeTraded2025-04-012025-12-3114728067core:MoreThanFiveYears2025-04-012025-12-3114728067core:Non-currentFinancialInstruments2025-12-3114728067core:Non-currentFinancialInstruments2025-03-3114728067dpl:CostSales2025-04-012025-12-3114728067dpl:DistributionCosts2025-04-012025-12-3114728067core:LandBuildings2025-04-012025-12-3114728067core:PlantMachinery2025-04-012025-12-3114728067core:Vehicles2025-04-012025-12-3114728067core:FurnitureFittings2025-04-012025-12-3114728067core:OfficeEquipment2025-04-012025-12-3114728067dpl:AdministrativeExpenses2025-04-012025-12-3114728067core:NetGoodwill2025-04-012025-12-3114728067core:IntangibleAssetsOtherThanGoodwill2025-04-012025-12-3114728067dpl:GroupUndertakings2025-04-012025-12-3114728067dpl:ParticipatingInterests2025-04-012025-12-3114728067dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012025-12-3114728067core:ListedExchangeTraded2025-04-012025-12-3114728067dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012025-12-3114728067core:UnlistedNon-exchangeTraded2025-04-012025-12-3114728067dpl:CostSales2024-04-012025-03-3114728067dpl:DistributionCosts2024-04-012025-03-3114728067core:LandBuildings2024-04-012025-03-3114728067core:PlantMachinery2024-04-012025-03-3114728067core:Vehicles2024-04-012025-03-3114728067core:FurnitureFittings2024-04-012025-03-3114728067core:OfficeEquipment2024-04-012025-03-3114728067dpl:AdministrativeExpenses2024-04-012025-03-3114728067core:NetGoodwill2024-04-012025-03-3114728067core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114728067dpl:GroupUndertakings2024-04-012025-03-3114728067dpl:ParticipatingInterests2024-04-012025-03-3114728067dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114728067core:ListedExchangeTraded2024-04-012025-03-3114728067dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114728067core:UnlistedNon-exchangeTraded2024-04-012025-03-3114728067core:NetGoodwill2025-12-3114728067core:IntangibleAssetsOtherThanGoodwill2025-12-3114728067core:LandBuildings2025-12-3114728067core:PlantMachinery2025-12-3114728067core:Vehicles2025-12-3114728067core:FurnitureFittings2025-12-3114728067core:OfficeEquipment2025-12-3114728067core:AfterOneYear2025-12-3114728067core:WithinOneYear2025-12-3114728067core:ListedExchangeTraded2025-12-3114728067core:UnlistedNon-exchangeTraded2025-12-3114728067core:ShareCapital2025-12-3114728067core:SharePremium2025-12-3114728067core:RevaluationReserve2025-12-3114728067core:OtherReservesSubtotal2025-12-3114728067core:RetainedEarningsAccumulatedLosses2025-12-3114728067core:NetGoodwill2025-03-3114728067core:IntangibleAssetsOtherThanGoodwill2025-03-3114728067core:LandBuildings2025-03-3114728067core:PlantMachinery2025-03-3114728067core:Vehicles2025-03-3114728067core:FurnitureFittings2025-03-3114728067core:OfficeEquipment2025-03-3114728067core:AfterOneYear2025-03-3114728067core:WithinOneYear2025-03-3114728067core:ListedExchangeTraded2025-03-3114728067core:UnlistedNon-exchangeTraded2025-03-3114728067core:ShareCapital2025-03-3114728067core:SharePremium2025-03-3114728067core:RevaluationReserve2025-03-3114728067core:OtherReservesSubtotal2025-03-3114728067core:RetainedEarningsAccumulatedLosses2025-03-3114728067core:NetGoodwill2024-03-3114728067core:IntangibleAssetsOtherThanGoodwill2024-03-3114728067core:LandBuildings2024-03-3114728067core:PlantMachinery2024-03-3114728067core:Vehicles2024-03-3114728067core:FurnitureFittings2024-03-3114728067core:OfficeEquipment2024-03-3114728067core:AfterOneYear2024-03-3114728067core:WithinOneYear2024-03-3114728067core:ListedExchangeTraded2024-03-3114728067core:UnlistedNon-exchangeTraded2024-03-3114728067core:ShareCapital2024-03-3114728067core:SharePremium2024-03-3114728067core:RevaluationReserve2024-03-3114728067core:OtherReservesSubtotal2024-03-3114728067core:RetainedEarningsAccumulatedLosses2024-03-3114728067core:AfterOneYear2025-04-012025-12-3114728067core:WithinOneYear2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012025-12-3114728067core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3114728067core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3114728067core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3114728067core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3114728067core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3114728067core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3114728067core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3114728067core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3114728067core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3114728067core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114728067core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114728067core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114728067core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114728067core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114728067core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114728067core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114728067core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114728067core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114728067bus:Director12025-04-012025-12-3114728067bus:Director22025-04-012025-12-3114728067bus:Director32025-04-012025-12-3114728067bus:Director42025-04-012025-12-31

GENETIX LIMITED

(formerly FUNGID LTD)

Registered Number
14728067
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2025

GENETIX LIMITED
Company Information
for the period from 1 April 2025 to 31 December 2025

Directors

PATERSON, James
POULTON, Barnaby John
PRASAD, Rishabh Bindah, Dr
SWEIDAN, Gary

Registered Address

31 Russell Street
Liverpool
L3 5LJ

Registered Number

14728067 (England and Wales)
GENETIX LIMITED
Balance Sheet as at
31 December 2025

Notes

31 Dec 2025

31 Mar 2025

£

£

£

£

Fixed assets
Intangible assets3253,704-
Tangible assets410,017-
263,721-
Current assets
Debtors556,284150
Cash at bank and on hand38,025121
94,309271
Creditors amounts falling due within one year6(156,920)(16,016)
Net current assets (liabilities)(62,611)(15,745)
Total assets less current liabilities201,110(15,745)
Creditors amounts falling due after one year7(109,670)-
Provisions for liabilities(2,504)-
Net assets88,936(15,745)
Capital and reserves
Called up share capital4,3341,000
Share premium500,000-
Profit and loss account(415,398)(16,745)
Shareholders' funds88,936(15,745)
The financial statements were approved and authorised for issue by the Board of Directors on 9 September 2026, and are signed on its behalf by:
SWEIDAN, Gary
Director
Registered Company No. 14728067
GENETIX LIMITED
Notes to the Financial Statements
for the period ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
2.Average number of employees

20252025
Average number of employees during the year60
3.Intangible assets

Total

£
Cost or valuation
Additions253,704
At 31 December 25253,704
Net book value
At 31 December 25253,704
At 31 March 25-
4.Tangible fixed assets

Total

£
Cost or valuation
Additions10,017
At 31 December 2510,017
Net book value
At 31 December 2510,017
At 31 March 25-
5.Debtors: amounts due within one year

2025

2025

££
Other debtors54,284150
Prepayments and accrued income2,000-
Total56,284150
6.Creditors: amounts due within one year

2025

2025

££
Trade creditors / trade payables9,840-
Taxation and social security6,973-
Other creditors139,49715,466
Accrued liabilities and deferred income610550
Total156,92016,016
7.Creditors: amounts due after one year

2025

2025

££
Other creditors109,670-
Total109,670-